Veriheal

Cannabis Telehealth Platform Veri Medtech Sets Terms for $15m Nasdaq IPO

Veriheal parent Veri Medtech Holdings has priced a $15m IPO at $4 per share, with plans to uplist from the OTC market to Nasdaq.

Rob Dale8 May 2026